Adoptive T cell therapy combined with intralesional administrations of TG1042 (adenovirus expressing interferon-γ) in metastatic melanoma patients-Reference-Cited by-同舟云学术

Adoptive T cell therapy combined with intralesional administrations of TG1042 (adenovirus expressing interferon-γ) in metastatic melanoma patients

Published:2015-04-07 Issue:7 Volume:64 Page:805-815
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Khammari Amir,Nguyen Jean-Michel,Saint-Jean Melanie,Knol Anne-Chantal,Pandolfino Marie-Christine,Quereux Gaelle,Brocard Anabelle,Peuvrel Lucie,Saiagh Soraya,Bataille Vincent,Limacher Jean-Marc,Dreno Brigitte

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-015-1691-7.pdf

Reference30 articles.

1. Restifo NP, Dudley ME, Rosenberg SA (2012) Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol 12:269–281

2. Kirkwood JM, Ernstoff MS (1990) Role of interferons in the therapy of melanoma. J Invest Dermatol 95:180S–184S

3. Nemunaitis J, Fong T, Robbins JM, Edelman G, Edwards W, Paulson RS, Bruce J, Ognoskie N, Wynne D, Pike M, Kowal K, Merritt J, Ando D (1999) Phase I trial of interferon-gamma (IFN-gamma) retroviral vector administered intratumorally to patients with metastatic melanoma. Cancer Gene Ther 6:322–330

4. Khorana AA, Rosenblatt JD, Sahasrabudhe DM, Evans T, Landrigan M, Marquis D, Rosell K, Whiteside T, Phillippe S, Acres B, Slos P, Squiban P, Ross M, Kendra K (2003) A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma. Cancer Gene Ther 10:251–259

5. Whittington R, Faulds D (1993) Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer. Drugs 46:446–514

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developing innovative strategies of tumor‑infiltrating lymphocyte therapy for tumor treatment;Oncology Reports;2024-04-26

2. Interleukin-2 and Oncolytic Virotherapy: A New Perspective in Cancer Therapy;Anti-Cancer Agents in Medicinal Chemistry;2023-11

3. Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and Challenges;Cancers;2022-08-27

4. Suppression effect of a dual cancer-specific oncolytic adenovirus on luciferase-labeled human melanoma cells in vitro and in vivo;Cancer Biomarkers;2021-11-10

5. Complete spontaneous regression of primary Merkel cell carcinoma with tumoural infiltration: a systematic review;European Journal of Dermatology;2021-06